Together for
the best diagnostic

We develop a wide portfolio of diagnostic tools
to support the emergence of innovative therapies.

We propose a wide portfolio
of radiopharmaceutical tracers

Nucleis is a radiopharmaceutical company which propose and manufacture Radiopharmaceutical Drugs for Diagnostic and Therapy Monitoring.

Nucleis is a spin-off from the University of Liège (Cyclotron Research Centre - Belgium) created to outsource the GMP manufacturing and distribution of PET (*Positron Emission Tomography) radiopharmaceutical drugs.

Our products

Our core business consists of three main activities:

  • FDG manufacturing and distribution. Glucotrace (fludeoxyglucose (18F))
  • Manufacturing and distribution of IP drugs as part of our CMO activities.
  • Manufacturing and distribution of generic pharmaceutical drugs for clinical trials. Investigational Medicinal Products - IMP and non-IMP
Nuclear Medicine
Manufacturing Distribution

Working together
for the best results

We are delivering our products and services to customers in 5 countries.

  • Belgium
  • Netherlands
  • Germany
  • France
  • Luxembourg
  • Germany
About Nucleis
Parmaceutical products
Team expertise
Disctribution